top of page

Wolfiporia extensa (Polyporaceae) Fu Ling, Poria, Tuckahoe, China Root

6 days ago
14 min read

Wolfiporia extensa is a wood-decay fungus with a subterranean growth habit, notable for forming a large, long-lasting sclerotium that resembles a small coconut and is harvested for medicine and food. Known as Fu Ling in Chinese medicine and Poria in Western herbal literature, the dried sclerotium has been used for millennia as a diuretic, sedative, and spleen-invigorating agent, and it appears in approximately ten percent of the medicinal preparations in the Pharmacopoeia of the People's Republic of China . Modern research has focused on two principal chemical groups, the polysaccharides (notably pachyman and its derivatives) and the lanostane triterpenes (notably pachymic acid), which demonstrate immunomodulatory, anti-inflammatory, anticancer, and bone-homeostasis activities in preclinical models. A nomenclatural note is essential here: the species has been known under several names, and the currently accepted name in major taxonomic databases requires clarification.


1. Taxonomic Insights


Species: Wolfiporia extensa (Peck) Ginns


Family: Polyporaceae


Genus: Wolfiporia


Basionym: Daedalea extensa Peck, 1891


Synonyms: Wolfiporia cocos (F.A. Wolf) Ryvarden & Gilb.; Poria cocos (Schwein.) F.A. Wolf; Sclerotium cocos Schwein.; Pachyma cocos Fr.; Macrohyporia extensa (Peck) Ginns & J. Lowe; Macrohyporia cocos (F.A. Wolf) I. Johans. & Ryvarden


Nomenclatural note: The taxonomy of this species has been confusing and remains unsettled in its details. The name Wolfiporia extensa (Peck) Ginns was published in 1984 and is treated as the correct name by Species Fungorum and by many reviews . However, the Korean National Institute of Biological Resources lists Wolfiporia cocos (F.A. Wolf) Ryvarden & Gilb. as the accepted name, with Wolfiporia extensa as a synonym . The Inxight Drugs database of the US National Center for Advancing Translational Sciences lists both Wolfiporia cocos and Wolfiporia extensa as associated names for the same organism . In the Chinese and Japanese pharmacological literature, the species is most frequently cited as Poria cocos, and this name remains widespread in clinical and experimental publications . The basionym Daedalea extensa Peck dates to 1891, while the earlier Sclerotium cocos Schwein. dates to 1822 and refers to the sclerotium rather than the basidiocarp . For the purposes of this monograph, Wolfiporia extensa is used in the title following Species Fungorum, with the caveat that Wolfiporia cocos and Poria cocos are the names most likely encountered in the medicinal literature.


Botanical Description


Wolfiporia extensa produces annual, resupinate basidiocarps that appear as small patches on wood and later coalesce and spread. The hymenium is poroid, with one to two angular pores per millimetre, and ranges from ochraceous to pinkish in colour. The flesh of the basidiocarp is thin, cream to pinkish . The more conspicuous structure is the hypogeal sclerotium, which forms among the roots of trees, particularly pines, and varies in shape from oblong to globose, measuring ten to thirty centimetres in length and sometimes weighing over one kilogram. The sclerotium surface is reddish-brown to dark brown and coarsely wrinkled; the interior is white and firm when dried . In Korea, the sclerotium forms ten to thirty centimetres below ground, attached to pine roots, and can exceed thirty centimetres in diameter and one kilogram in weight .


Distribution: The species occurs in East Asia, including Korea, China, and Japan, as well as in North America. In Japan, it has been recorded from Honshu, Shikoku, and Kyushu, and is considered vulnerable in Ehime Prefecture due to declining sightings since the 1960s . Korean populations are described as forming sclerotia throughout the Korean peninsula .


Conservation Status: Not globally evaluated as threatened. In Japan, it is listed as Vulnerable in Ehime Prefecture, reflecting local rarity and the difficulty of detecting a hypogeal fungus . Commercial supplies are predominantly cultivated rather than wild-collected, with Chinese production estimated at ten thousand to thirteen thousand tonnes of sclerotia annually .


Etymology


The generic name Wolfiporia honours F.A. Wolf, who studied the fungus, and the genus Poria. The specific epithet extensa refers to the spreading nature of the basidiocarp. The common names are numerous: Fu Ling in Chinese, Bokryung in Korean, Bukuryo in Japanese, and Poria, Tuckahoe, or China Root in English . The name Tuckahoe is shared with an unrelated North American plant, Peltandra virginica, and confusion between the two should be avoided .


2. Common Names


Scientific Name: Wolfiporia extensa | English: Poria, Tuckahoe, China Root, Hoelen | Chinese: Fu Ling, Fu Shen (the core of the sclerotium) | Korean: Bokryung | Japanese: Bukuryo | Polish: (used in Polish-language sources as Wolfiporia extensa)


3. Related Herbs from the Polyporaceae Family


Wolfiporia extensa belongs to the Polyporaceae, a family of wood-decay fungi that includes many medicinal and edible mushrooms. Within Wolfiporia, W. cocos is the name most commonly used in the pharmacological literature for the same organism treated here .


Ganoderma lucidum (Reishi): A polypore with a long history in Chinese medicine, studied for immunomodulatory and anticancer polysaccharides and triterpenes.


Trametes versicolor (Turkey Tail): A polypore whose polysaccharide fraction (PSK) is used as an adjunct in cancer therapy in Japan.


Poria species other than W. extensa: The genus Poria in older literature is polyphyletic, and many species formerly placed there have been transferred to other genera. The medicinal Fu Ling is specifically W. extensa .


The Polyporaceae are characterized by the production of high-molecular-weight polysaccharides, particularly beta-glucans, and in some genera lanostane triterpenes, which contribute to immunomodulatory and anti-inflammatory activities.


4. Medicinal Uses: Summary of Primary and Secondary Actions


Primary Actions:


Diuretic and damp-draining: The dried sclerotium is used in traditional Chinese medicine to promote urination and drain dampness, indications that include dysuria, oedema, and phlegm retention .


Spleen-invigorating and digestive: Used to invigorate the spleen function (digestive function in biomedical terms), for poor appetite and watery stool .


Sedative and mind-calming: Used for palpitations and insomnia. The core portion of the sclerotium, known as Fu Shen, is specifically used to calm the heart and spirit and improve sleep .


Secondary Actions:


Anti-inflammatory: Preclinical studies demonstrate inhibition of NF-kappa-B, MAPK, and HIF-1 signalling pathways, with reduction of TNF-alpha, IL-6, and nitric oxide in animal models of skin, kidney, and liver inflammation .


Immunomodulatory: Beta-glucans from the sclerotium can both enhance weakened immunity and inhibit excessive immune activity, with effects on macrophage activity and NF-kappa-B signalling .


Anticancer: Polysaccharide and triterpene fractions demonstrate cytotoxicity against multiple human cancer cell lines and antitumour effects in animal models, with proposed mechanisms including NF-kappa-B downregulation, antiangiogenesis, and apoptosis induction .


Bone homeostasis: Mycelium extracts promote osteoblast differentiation and inhibit osteoclast differentiation in vitro, suggesting potential for osteoporosis prevention and treatment .


Antidiabetic: Animal studies indicate that extracts may lower blood glucose and improve insulin sensitivity; pachymic acid enhances glucose uptake and GLUT4 transporter expression in adipocytes .


Medicinal Parts


Sclerotium: The principal medicinal part. The whole dried sclerotium is Fu Ling; the inner core is Fu Shen, used particularly for sleep and palpitations .


Mycelium: Cultivated mycelium is used in research and in some commercial products, and contains polysaccharides and triterpenes comparable to the sclerotium .


5. Phytochemistry


5.1 Polysaccharides


The principal polysaccharide is pachyman, a beta-(1,3)-D-glucan with beta-(1,2) and beta-(1,6) branches, constituting approximately 55.8 percent of the polysaccharide fraction. Other polysaccharide fractions (PCM1, PCM2, PCM4) contain varying combinations of rhamnose, fucose, xylose, mannose, galactose, glucose, and glucuronic acid . Derivatives including U-pachyman, pachymaran, and carboxymethyl pachymaran have demonstrated anticancer effects, and (1,3)-(1,6)-pachymaran has strong antitumour activity .


5.2 Triterpenes


Over one hundred triterpenoids have been identified, with pachymic acid being the most extensively studied. Other lanostane derivatives include polyporenic acid C, tumulosic acid, dehydrotumulosic acid, and dehydropachymic acid . The pachymic acid content of the sclerotium ranges from 0.79 to 1.19 milligrams per gram in the inner portion and 1.49 to 1.94 milligrams per gram in the outer skin, varying with cultivation region and method .


5.3 Other Constituents


Ergosterol and fatty acids are present, and GC-MS analysis of ethanol extracts has identified oleic acid . Elemental analysis of Korean-cultivated material found sulphur at 145 to 149 parts per million, magnesium at 69 to 72 parts per million, phosphorus at 122 to 154 parts per million, and calcium at 210 to 510 parts per million, with regional variation .


6. Mechanisms of Action


6.1 Anti-inflammatory: Network Pharmacology and Pathway Inhibition


A network pharmacology study of the methanol extract identified twenty-seven bioactive compounds, all obeying Lipinski's rules, and mapped them to forty-two common targets shared with inflammation pathways. KEGG analysis pointed to the HIF-1 signalling pathway as a central node, with the downstream inhibition of NF-kappa-B, MAPK, mTOR, and PI3K-Akt cascades proposed as the mechanism for preventing the inflammatory response. Molecular docking revealed the strongest binding affinity for N-(3-chlorophenyl) naphthyl carboxamide on five target proteins associated with HIF-1 signalling, and density functional theory analysis indicated favourable electron-donating and chemical hardness properties compared with standard drugs . This computational work complements earlier experimental studies in which triterpene carboxylic acids inhibited ear and paw oedema in mice and pachymic acid inhibited phospholipase A2 .


6.2 Bone Homeostasis: Dual Action on Osteoblasts and Osteoclasts


A screen of twenty-eight W. extensa mycelium strains, comprising cultivated, wild, and hybrid strains, demonstrated that the extracts can both enhance osteoblast differentiation and inhibit osteoclast differentiation in vitro. This dual action on bone formation and resorption is proposed as a basis for osteoporosis prevention and treatment, and the authors note that mycelium contains higher concentrations of ergosterol and phenolic compounds than the fruiting body .


6.3 Immunomodulation: Beta-Glucan Receptor Interactions


The beta-glucans, particularly pachyman and its derivatives, interact with pattern recognition receptors on immune cells, including dectin-1, to modulate macrophage and dendritic cell activity. The outcome can be either enhancement of weakened immune responses or suppression of excessive activation, depending on context, and the NF-kappa-B pathway is a central mediator .


7. Traditional and Ethnobotanical Uses


7.1 Diuresis, Oedema, and Dampness


Formulation: Dried sclerotium in decoction or powder, often in combination formulas.


Preparation and Use: Fu Ling is a component of numerous classical Chinese formulas for oedema, dysuria, and phlegm retention. It is typically decocted with other herbs .


Scientific Validation: The diuretic use is deeply embedded in traditional practice but has not been subjected to modern controlled trials as a single agent. Most clinical evidence is based on combination preparations, which cannot be evaluated for the efficacy of poria alone .


7.2 Insomnia and Palpitations


Formulation: Fu Shen, the inner core of the sclerotium, in decoction or powder.


Preparation and Use: Used to calm the heart and spirit and improve sleep. One source notes that a study used 800 milligrams of ethanol extract daily before sleep, though human clinical data remain scarce .


Scientific Validation: Animal studies and preliminary data suggest improvement in sleep quality, possibly through pachymic acid stimulation of serotonin release. Human data require confirmation .


7.3 Digestive Weakness and Poor Appetite


Formulation: Dried sclerotium in combination formulas.


Preparation and Use: Used to invigorate the spleen and stomach, for poor appetite and watery stool .


Scientific Validation: Traditional use only; no controlled trials as a single agent.


7.4 Cancer Adjuvant Use


Formulation: Polysaccharide or triterpene fractions, or whole sclerotium in combination with conventional therapy.


Preparation and Use: In Chinese clinical practice, poria is included in multi-herb formulas as an adjuvant to chemotherapy. A systematic review of herbal adjuvants to FOLFOX4 for colorectal cancer identified Poria cocos as the sixth most common herb among thirteen trials and 940 patients, though the heterogeneity of formulas precludes attribution of benefit to poria alone .


Scientific Validation: Preclinical anticancer activity is well documented, but clinical evidence for poria as a single agent is absent .


8. Healing Recipes, Teas, Decoctions, and Practical Applications


8.1 Fu Ling Decoction for Digestive Weakness and Oedema (Traditional Use)


Purpose: Traditional remedy for poor appetite, watery stool, and mild oedema.


Preparation and Use: Dried sclerotium is decocted in water, typically in combination with other herbs such as Atractylodes and ginger according to classical formulas. Precise proportions vary by formula and are not standardized in the accessible literature.


Scientific Validation: Traditional use; no controlled trials of poria alone. The diuretic and digestive indications are supported by centuries of clinical practice in Chinese medicine but not by modern evidence-based standards.


8.2 Fu Shen Preparation for Sleep (Traditional and Preliminary Evidence)


Purpose: To calm the spirit and improve sleep.


Preparation and Use: The inner core of the sclerotium (Fu Shen) is used in decoction or powder. One source mentions 800 milligrams of ethanol extract before sleep, though this is not a standardized recommendation .


Scientific Validation: Preliminary animal and human data suggest benefit, but clinical evidence is insufficient for a firm recommendation. Sedative medication should not be discontinued without medical supervision.


8.3 Poria-Containing Cream for Contact Dermatitis (Clinical Observation)


Purpose: Topical application for inflammatory skin conditions.


Preparation and Use: In a human volunteer study, poria incorporated into an amphiphilic emollient cream was effective in the induction phase of contact dermatitis but not in well-established inflammation. The cream was not irritating to healthy skin .


Scientific Validation: This is one of the few human studies of poria as a topical agent. The results are preliminary and limited to a specific experimental model. It does not support general use for eczema or dermatitis without further study.


9. Clinical Significance and Evidence Summary


9.1 Evidence Hierarchy by Activity


Anti-inflammatory: Moderate preclinical evidence from network pharmacology, animal models, and one human topical study. The molecular pathways are well characterized, but clinical trials of oral poria for inflammatory conditions are lacking .


Bone homeostasis: Moderate in vitro evidence from mycelium extracts showing dual osteoblast-promoting and osteoclast-inhibiting activity. No animal or human studies of bone density or fracture outcomes were identified .


Immunomodulation: Moderate preclinical evidence for beta-glucan effects on immune cells. Clinical trials are lacking .


Anticancer: Preclinical evidence from cell lines and animal models. Clinical evidence is limited to combination formulas in which poria is one of many herbs, precluding attribution of effect .


Diuretic, sedative, and digestive uses: Traditional use with minimal modern clinical validation as a single agent .


9.2 Safety and Toxicology Data


The Chinese Pharmacopoeia lists poria as contraindicated in polyuria, spermatorrhea, and urogenital prolapse . No well-documented adverse reactions were identified in the Drugs.com professional monograph . Safety in pregnancy and lactation is unknown, and use should be avoided . The Polish-language source notes that the extract may potentiate sedatives, hypnotics, diuretics, antihypertensives, and cholinergic or anticholinergic drugs, and recommends discontinuation at least two weeks before surgery due to potential enhancement of anaesthetic effects and excessive central nervous system depression .


10. Safety and Toxicology


10.1 Toxicity Profile


Acute Toxicity: No systematic acute toxicity data were identified in the available search results.


Clinical Safety: Long history of use in Chinese medicine. No well-documented adverse reactions were found in the Drugs.com monograph . The primary safety concerns relate to contraindications and drug interactions rather than direct toxicity.


10.2 Contraindications and Precautions


Polyuria, Spermatorrhea, and Urogenital Prolapse: Listed as contraindications in the Chinese Pharmacopoeia .


Pregnancy and Lactation: Avoid use due to lack of safety data .


Surgery: Discontinue at least two weeks before planned surgery due to potential enhancement of anaesthetics and central nervous system depression .


10.3 Potential Drug Interactions


Sedatives and Hypnotics: Additive central nervous system depression is possible .


Diuretics and Antihypertensives: Additive effects on fluid balance and blood pressure are possible .


Cholinergic and Anticholinergic Drugs: The extract may affect cholinergic transmission .


Anaesthetics: Enhanced anaesthetic effect and excessive central nervous system depression are concerns; discontinuation before surgery is advised .


11. Quality Control Parameters


11.1 Marker Compounds for Standardisation


For polysaccharide-rich preparations, total polysaccharide content and pachyman or beta-glucan content are appropriate markers. For triterpene-rich preparations, pachymic acid is the best-established marker, with a validated range of 0.79 to 1.19 milligrams per gram in the inner sclerotium and 1.49 to 1.94 milligrams per gram in the outer skin .


11.2 Recommended Analytical Methods


High-performance liquid chromatography (HPLC) is suitable for quantification of pachymic acid and related triterpenes. Colorimetric methods or HPLC can be used for total polysaccharide and beta-glucan content. GC-MS is useful for profiling fatty acids and volatile constituents . Given that the fungus grows underground and may accumulate soil contaminants, heavy metal and microbiological testing are essential quality parameters .


11.3 Suggested Specifications


Commercial products should specify polysaccharide content (commonly standardized to 10 to 50 percent) and pachymic acid content. Heavy metal limits and microbiological safety should be specified. Regional variation in calcium and other mineral content is documented and should be considered in sourcing .


11.4 Adulteration and Market Quality Concerns


The primary quality concern is contamination with heavy metals and microbes from the soil environment, given the hypogeal growth habit . Confusion with other fungi sold as "poria" or "tuckahoe" is possible. Botanical and chemical authentication of sclerotium material is advisable. Most commercial material originates from China, and sourcing from reputable cultivators with quality testing is recommended .


12. Cultivation and Sustainability


12.1 Growth Requirements


Climate: Temperate to subtropical, associated with pine forests.


Habitat: Grows underground among the roots of pines and occasionally oaks, forming a large sclerotium ten to thirty centimetres below the soil surface .


Propagation: Cultivated on cut pine logs. In China, pine trunks are cut in autumn and laid on the ground for six months; the following spring, holes are made in the logs and mycelium is introduced. Sclerotia develop over several months .


12.2 Sustainable Harvesting


Wild harvesting is possible but most commercial supply is cultivated. Cultivation on pine logs provides a renewable supply and reduces pressure on wild populations, which are locally rare in parts of Japan .


12.3 Conservation Status


Not globally threatened. Locally vulnerable in Ehime Prefecture, Japan, where sightings have declined since the 1960s . Cultivation dominates commercial supply.


12.4 Ecological Role and Sustainability Challenges


As a wood-decay fungus, W. extensa participates in nutrient cycling in forest ecosystems. The main sustainability challenge is meeting commercial demand, which is largely addressed through cultivation. Wild populations in regions such as Japan may warrant monitoring, but the species is not considered globally at risk.


13. Cultivar and Varietal Comparison


No formally recognized cultivars are described in the medicinal literature. Research has screened cultivated, wild, and hybrid strains of W. extensa mycelium for osteogenic activity, finding variation among strains in their ability to promote osteoblast differentiation and inhibit osteoclast differentiation . This suggests that strain selection may be relevant for medicinal product development, but no named cultivars are in commercial use.


14. Research Gaps and Future Directions


14.1 Critical Research Gaps


Clinical Trials: Controlled trials of W. extensa as a single agent are almost entirely lacking. Most clinical evidence comes from combination formulas in which attribution of effect is impossible .


Bioavailability and Pharmacokinetics: No absorption, distribution, metabolism, or excretion data were identified for pachymic acid or the polysaccharide fractions in humans.


Bone Health: The promising in vitro evidence for dual osteoblast and osteoclast effects has not been tested in animal models of bone loss or in human trials .


Standardization: The variability in pachymic acid content by region and plant part, and the complexity of the polysaccharide fraction, present challenges for reproducible product development .


14.2 Future Research Priorities


Bone Health Clinical Development: The mycelium-based bone homeostasis data justify progression to animal studies and, if supported, to human trials with standardized extracts.


Anti-inflammatory Clinical Trials: The network pharmacology and animal data support clinical evaluation in inflammatory conditions, particularly given the favourable safety profile suggested by long traditional use.


Standardized Extract Development: Research to define optimal marker compounds and specifications for both polysaccharide and triterpene fractions would support evidence-based product development.


15. Commercial Applications


15.1 Herbal Medicine and Nutraceutical Products


Poria is widely available as dried sclerotium, slices, powder, and standardized extracts. It is a component of numerous traditional Chinese medicine formulas and is also sold as a single-ingredient dietary supplement. Products standardized to polysaccharide content (commonly 10 to 50 percent) are marketed for immune support, and pachymic acid content is used as a quality marker .


15.2 Food and Culinary Use


The sclerotium is considered edible and safe for human consumption, with a sweet taste and soft consistency. It has been used as food in the United States, where roasted sclerotia were eaten, and is included in the FAO list of wild fungi of economic importance . Tuckahoe pie is a traditional preparation in some regions .


15.3 Research Reagent


Pachyman, pachymic acid, and the polysaccharide fractions are used as research reagents in immunology, cancer biology, and bone metabolism studies.


16. Related Plants for Further Study


Ganoderma lucidum: Another medicinal polypore with extensively studied polysaccharide and triterpene fractions; comparative immunology and oncology research.


Trametes versicolor: A polypore with a clinically used polysaccharide fraction (PSK) in cancer adjuvant therapy; a model for clinical development of fungal polysaccharides.


Poria species other than W. extensa: The genus is polyphyletic, and comparative study of related fungi may clarify the specificity of Fu Ling's traditional indications.


17. Reference Literature


Primary Research


Jin J, et al. Bioactive Compounds and Signaling Pathways of Wolfiporia extensa in Suppressing Inflammatory Response by Network Pharmacology. Life (Basel). 2023;13(4):893. This study identifies twenty-seven bioactive compounds and proposes HIF-1 pathway inhibition with downstream NF-kappa-B, MAPK, mTOR, and PI3K-Akt suppression as the anti-inflammatory mechanism .


Inhibition of Osteoclast Differentiation and Promotion of Osteogenic Formation by Wolfiporia extensa Mycelium. Europe PMC. 2023. This study screens twenty-eight mycelium strains and demonstrates dual action on osteoblast and osteoclast differentiation .


Choi SH, et al. Comparison of Ingredients and Antioxidant Activity of Wolfiporia extensa Cultured in Different Regions of Korea. Korean Journal of Mycology. 2016;44(1):23. This study documents regional variation in mineral content and antioxidant activity, and identifies oleic acid in ethanol extracts .


Review Literature


Ríos JL. Interés medicinal de Poria cocos (= Wolfiporia extensa). Revista Iberoamericana de Micología. 2009. This review summarizes taxonomy, nomenclature, chemical composition, and therapeutic applications, including the polysaccharide pachyman and its structure .


Poria. Drugs.com Professional Monograph. 2023. This monograph summarizes uses, pharmacology, safety, contraindications, and drug interactions based on the published literature .


Taxonomic References


Species Fungorum. Wolfiporia extensa (Peck) Ginns. Provides basionym, publication details, and current name status .


Korean National Institute of Biological Resources. Wolfiporia cocos (F.A. Wolf) Ryvarden & Gilb. Lists Wolfiporia extensa as a synonym and provides Korean distribution and description .


18. Disclaimer


Wolfiporia extensa has a long history of traditional use in Chinese medicine and a favourable safety profile in customary use, but controlled clinical trials as a single agent are almost entirely lacking. Most clinical evidence comes from combination formulas in which attribution of effect to this species alone is impossible.


This information is for educational and academic purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.


The Chinese Pharmacopoeia lists poria as contraindicated in polyuria, spermatorrhea, and urogenital prolapse.


Avoid use in pregnancy and lactation due to lack of safety data.


Discontinue at least two weeks before planned surgery due to potential enhancement of anaesthetic effects and central nervous system depression.


The extract may potentiate sedatives, hypnotics, diuretics, antihypertensives, and cholinergic or anticholinergic drugs. Consult a healthcare professional before combining with prescription medications.


Always consult a qualified healthcare practitioner before using any medicinal fungus.

Related Posts

See All

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page